Impact of COVID-19 Outbreak on Novel Drug Delivery Systems for Cancer Therapy, Global Market Research Report 2020

Publisher Name :
Date: 01-May-2020
No. of pages: 134
Inquire Before Buying

This report focuses on the global Novel Drug Delivery Systems for Cancer Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Novel Drug Delivery Systems for Cancer Therapy development in North America, Europe, China and Japan.

The key players covered in this study

- Advanced Medical Isotope Corporation

- Bind Therapeutics

- Boston Scientific Corporation

- BTG plc

- CeloNova BioSciences, Inc.

- Cook Medical, Inc.

- Cospheric LLC

- Covidien, plc

- Eckert & Ziegler BEBIG

- EmboMedics, Inc.

- Kobo Products, Inc.

- Merit Medical Systems, Inc.

- Mo-Sci Corporation

- Nanobiotix

- Polysciences, Inc.

- Sirtex Medical, Inc.

- Terumo Corporation

Market segment by Type, the product can be split into

- Embolization Particles - Drug Eluting Beads

- Polyvinyl Alcohol Particles

- Microspheres

- Gelatin-Based Embolization Devices

- Selective Internal Radiation Therapy

- Holmium-Based Microspheres

- Liquid Embolics - Onyx

- Other

Market segment by Application, split into

- Hospitals

- Clinics

- Others

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

The study objectives of this report are:

- To analyze global Novel Drug Delivery Systems for Cancer Therapy status, future forecast, growth opportunity, key market and key players.

- To present the Novel Drug Delivery Systems for Cancer Therapy development in North America, Europe, China and Japan.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Novel Drug Delivery Systems for Cancer Therapy are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Impact of COVID-19 Outbreak on Novel Drug Delivery Systems for Cancer Therapy, Global Market Research Report 2020

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Novel Drug Delivery Systems for Cancer Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Embolization Particles - Drug Eluting Beads
1.4.3 Polyvinyl Alcohol Particles
1.4.4 Microspheres
1.4.5 Gelatin-Based Embolization Devices
1.4.6 Selective Internal Radiation Therapy
1.4.7 Holmium-Based Microspheres
1.4.8 Liquid Embolics - Onyx
1.4.9 Other
1.5 Market by Application
1.5.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Novel Drug Delivery Systems for Cancer Therapy Industry Impact
1.6.1 How the Covid-19 is Affecting the Novel Drug Delivery Systems for Cancer Therapy Industry
1.6.1.1 Novel Drug Delivery Systems for Cancer Therapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Novel Drug Delivery Systems for Cancer Therapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Novel Drug Delivery Systems for Cancer Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Novel Drug Delivery Systems for Cancer Therapy Market Perspective (2015-2026)
2.2 Novel Drug Delivery Systems for Cancer Therapy Growth Trends by Regions
2.2.1 Novel Drug Delivery Systems for Cancer Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Novel Drug Delivery Systems for Cancer Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Novel Drug Delivery Systems for Cancer Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Novel Drug Delivery Systems for Cancer Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Novel Drug Delivery Systems for Cancer Therapy Players by Market Size
3.1.1 Global Top Novel Drug Delivery Systems for Cancer Therapy Players by Revenue (2015-2020)
3.1.2 Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Novel Drug Delivery Systems for Cancer Therapy Market Concentration Ratio
3.2.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Novel Drug Delivery Systems for Cancer Therapy Revenue in 2019
3.3 Novel Drug Delivery Systems for Cancer Therapy Key Players Head office and Area Served
3.4 Key Players Novel Drug Delivery Systems for Cancer Therapy Product Solution and Service
3.5 Date of Enter into Novel Drug Delivery Systems for Cancer Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Novel Drug Delivery Systems for Cancer Therapy Historic Market Size by Type (2015-2020)
4.2 Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Type (2021-2026)
5 Novel Drug Delivery Systems for Cancer Therapy Breakdown Data by Application (2015-2026)
5.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Application (2015-2020)
5.2 Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Novel Drug Delivery Systems for Cancer Therapy Market Size (2015-2020)
6.2 Novel Drug Delivery Systems for Cancer Therapy Key Players in North America (2019-2020)
6.3 North America Novel Drug Delivery Systems for Cancer Therapy Market Size by Type (2015-2020)
6.4 North America Novel Drug Delivery Systems for Cancer Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size (2015-2020)
7.2 Novel Drug Delivery Systems for Cancer Therapy Key Players in Europe (2019-2020)
7.3 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size by Type (2015-2020)
7.4 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size by Application (2015-2020)
8 China
8.1 China Novel Drug Delivery Systems for Cancer Therapy Market Size (2015-2020)
8.2 Novel Drug Delivery Systems for Cancer Therapy Key Players in China (2019-2020)
8.3 China Novel Drug Delivery Systems for Cancer Therapy Market Size by Type (2015-2020)
8.4 China Novel Drug Delivery Systems for Cancer Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Novel Drug Delivery Systems for Cancer Therapy Market Size (2015-2020)
9.2 Novel Drug Delivery Systems for Cancer Therapy Key Players in Japan (2019-2020)
9.3 Japan Novel Drug Delivery Systems for Cancer Therapy Market Size by Type (2015-2020)
9.4 Japan Novel Drug Delivery Systems for Cancer Therapy Market Size by Application (2015-2020)
10Key Players Profiles
10.1 Advanced Medical Isotope Corporation
10.1.1 Advanced Medical Isotope Corporation Company Details
10.1.2 Advanced Medical Isotope Corporation Business Overview and Its Total Revenue
10.1.3 Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Introduction
10.1.4 Advanced Medical Isotope Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020))
10.1.5 Advanced Medical Isotope Corporation Recent Development
10.2 Bind Therapeutics
10.2.1 Bind Therapeutics Company Details
10.2.2 Bind Therapeutics Business Overview and Its Total Revenue
10.2.3 Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Introduction
10.2.4 Bind Therapeutics Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
10.2.5 Bind Therapeutics Recent Development
10.3 Boston Scientific Corporation
10.3.1 Boston Scientific Corporation Company Details
10.3.2 Boston Scientific Corporation Business Overview and Its Total Revenue
10.3.3 Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Introduction
10.3.4 Boston Scientific Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
10.3.5 Boston Scientific Corporation Recent Development
10.4 BTG plc
10.4.1 BTG plc Company Details
10.4.2 BTG plc Business Overview and Its Total Revenue
10.4.3 BTG plc Novel Drug Delivery Systems for Cancer Therapy Introduction
10.4.4 BTG plc Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
10.4.5 BTG plc Recent Development
10.5 CeloNova BioSciences, Inc.
10.5.1 CeloNova BioSciences, Inc. Company Details
10.5.2 CeloNova BioSciences, Inc. Business Overview and Its Total Revenue
10.5.3 CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
10.5.4 CeloNova BioSciences, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
10.5.5 CeloNova BioSciences, Inc. Recent Development
10.6 Cook Medical, Inc.
10.6.1 Cook Medical, Inc. Company Details
10.6.2 Cook Medical, Inc. Business Overview and Its Total Revenue
10.6.3 Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
10.6.4 Cook Medical, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
10.6.5 Cook Medical, Inc. Recent Development
10.7 Cospheric LLC
10.7.1 Cospheric LLC Company Details
10.7.2 Cospheric LLC Business Overview and Its Total Revenue
10.7.3 Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Introduction
10.7.4 Cospheric LLC Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
10.7.5 Cospheric LLC Recent Development
10.8 Covidien, plc
10.8.1 Covidien, plc Company Details
10.8.2 Covidien, plc Business Overview and Its Total Revenue
10.8.3 Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Introduction
10.8.4 Covidien, plc Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
10.8.5 Covidien, plc Recent Development
10.9 Eckert & Ziegler BEBIG
10.9.1 Eckert & Ziegler BEBIG Company Details
10.9.2 Eckert & Ziegler BEBIG Business Overview and Its Total Revenue
10.9.3 Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Introduction
10.9.4 Eckert & Ziegler BEBIG Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
10.9.5 Eckert & Ziegler BEBIG Recent Development
10.10 EmboMedics, Inc.
10.10.1 EmboMedics, Inc. Company Details
10.10.2 EmboMedics, Inc. Business Overview and Its Total Revenue
10.10.3 EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
10.10.4 EmboMedics, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
10.10.5 EmboMedics, Inc. Recent Development
10.11 Kobo Products, Inc.
10.11.1 Kobo Products, Inc. Company Details
10.11.2 Kobo Products, Inc. Business Overview and Its Total Revenue
10.11.3 Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
10.11.4 Kobo Products, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
10.11.5 Kobo Products, Inc. Recent Development
10.12 Merit Medical Systems, Inc.
10.12.1 Merit Medical Systems, Inc. Company Details
10.12.2 Merit Medical Systems, Inc. Business Overview and Its Total Revenue
10.12.3 Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
10.12.4 Merit Medical Systems, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
10.12.5 Merit Medical Systems, Inc. Recent Development
10.13 Mo-Sci Corporation
10.13.1 Mo-Sci Corporation Company Details
10.13.2 Mo-Sci Corporation Business Overview and Its Total Revenue
10.13.3 Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Introduction
10.13.4 Mo-Sci Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
10.13.5 Mo-Sci Corporation Recent Development
10.14 Nanobiotix
10.14.1 Nanobiotix Company Details
10.14.2 Nanobiotix Business Overview and Its Total Revenue
10.14.3 Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Introduction
10.14.4 Nanobiotix Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
10.14.5 Nanobiotix Recent Development
10.15 Polysciences, Inc.
10.15.1 Polysciences, Inc. Company Details
10.15.2 Polysciences, Inc. Business Overview and Its Total Revenue
10.15.3 Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
10.15.4 Polysciences, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
10.15.5 Polysciences, Inc. Recent Development
10.16 Sirtex Medical, Inc.
10.16.1 Sirtex Medical, Inc. Company Details
10.16.2 Sirtex Medical, Inc. Business Overview and Its Total Revenue
10.16.3 Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
10.16.4 Sirtex Medical, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
10.16.5 Sirtex Medical, Inc. Recent Development
10.17 Terumo Corporation
10.17.1 Terumo Corporation Company Details
10.17.2 Terumo Corporation Business Overview and Its Total Revenue
10.17.3 Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Introduction
10.17.4 Terumo Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
10.17.5 Terumo Corporation Recent Development
11Analyst's Viewpoints/Conclusions
12Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
List of Tables
Table 1. Novel Drug Delivery Systems for Cancer Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Novel Drug Delivery Systems for Cancer Therapy Revenue
Table 3. Ranking of Global Top Novel Drug Delivery Systems for Cancer Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Embolization Particles - Drug Eluting Beads
Table 6. Key Players of Polyvinyl Alcohol Particles
Table 7. Key Players of Microspheres
Table 8. Key Players of Gelatin-Based Embolization Devices
Table 9. Key Players of Selective Internal Radiation Therapy
Table 10. Key Players of Holmium-Based Microspheres
Table 11. Key Players of Liquid Embolics - Onyx
Table 12. Key Players of Other
Table 13. COVID-19 Impact Global Market: (Four Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast Scenarios)
Table 14. Opportunities and Trends for Novel Drug Delivery Systems for Cancer Therapy Players in the COVID-19 Landscape
Table 15. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 16. Key Regions/Countries Measures against Covid-19 Impact
Table 17. Proposal for Novel Drug Delivery Systems for Cancer Therapy Players to Combat Covid-19 Impact
Table 18. Global Novel Drug Delivery Systems for Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 19. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 20. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 21. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Regions (2015-2020)
Table 22. Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 23. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Regions (2021-2026)
Table 24. Market Top Trends
Table 25. Key Drivers: Impact Analysis
Table 26. Key Challenges
Table 27. Novel Drug Delivery Systems for Cancer Therapy Market Growth Strategy
Table 28. Main Points Interviewed from Key Novel Drug Delivery Systems for Cancer Therapy Players
Table 29. Global Novel Drug Delivery Systems for Cancer Therapy Revenue by Players (2015-2020) (Million US$)
Table 30. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Players (2015-2020)
Table 31. Global Top Novel Drug Delivery Systems for Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Novel Drug Delivery Systems for Cancer Therapy as of 2019)
Table 32. Global Novel Drug Delivery Systems for Cancer Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 33. Key Players Headquarters and Area Served
Table 34. Key Players Novel Drug Delivery Systems for Cancer Therapy Product Solution and Service
Table 35. Date of Enter into Novel Drug Delivery Systems for Cancer Therapy Market
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 38. Global Novel Drug Delivery Systems for Cancer Therapy Market Size Share by Type (2015-2020)
Table 39. Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Type (2021-2026)
Table 40. Global Novel Drug Delivery Systems for Cancer Therapy Market Size Share by Application (2015-2020)
Table 41. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 42. Global Novel Drug Delivery Systems for Cancer Therapy Market Size Share by Application (2021-2026)
Table 43. North America Key Players Novel Drug Delivery Systems for Cancer Therapy Revenue (2019-2020) (Million US$)
Table 44. North America Key Players Novel Drug Delivery Systems for Cancer Therapy Market Share (2019-2020)
Table 45. North America Novel Drug Delivery Systems for Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 46. North America Novel Drug Delivery Systems for Cancer Therapy Market Share by Type (2015-2020)
Table 47. North America Novel Drug Delivery Systems for Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 48. North America Novel Drug Delivery Systems for Cancer Therapy Market Share by Application (2015-2020)
Table 49. Europe Key Players Novel Drug Delivery Systems for Cancer Therapy Revenue (2019-2020) (Million US$)
Table 50. Europe Key Players Novel Drug Delivery Systems for Cancer Therapy Market Share (2019-2020)
Table 51. Europe Novel Drug Delivery Systems for Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 52. Europe Novel Drug Delivery Systems for Cancer Therapy Market Share by Type (2015-2020)
Table 53. Europe Novel Drug Delivery Systems for Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 54. Europe Novel Drug Delivery Systems for Cancer Therapy Market Share by Application (2015-2020)
Table 55. China Key Players Novel Drug Delivery Systems for Cancer Therapy Revenue (2019-2020) (Million US$)
Table 56. China Key Players Novel Drug Delivery Systems for Cancer Therapy Market Share (2019-2020)
Table 57. China Novel Drug Delivery Systems for Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 58. China Novel Drug Delivery Systems for Cancer Therapy Market Share by Type (2015-2020)
Table 59. China Novel Drug Delivery Systems for Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 60. China Novel Drug Delivery Systems for Cancer Therapy Market Share by Application (2015-2020)
Table 61. Japan Key Players Novel Drug Delivery Systems for Cancer Therapy Revenue (2019-2020) (Million US$)
Table 62. Japan Key Players Novel Drug Delivery Systems for Cancer Therapy Market Share (2019-2020)
Table 63. Japan Novel Drug Delivery Systems for Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 64. Japan Novel Drug Delivery Systems for Cancer Therapy Market Share by Type (2015-2020)
Table 65. Japan Novel Drug Delivery Systems for Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 66. Japan Novel Drug Delivery Systems for Cancer Therapy Market Share by Application (2015-2020)
Table 67. Advanced Medical Isotope Corporation Company Details
Table 68. Advanced Medical Isotope Corporation Business Overview
Table 69. Advanced Medical Isotope Corporation Product
Table 70. Advanced Medical Isotope Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 71. Advanced Medical Isotope Corporation Recent Development
Table 72. Bind Therapeutics Company Details
Table 73. Bind Therapeutics Business Overview
Table 74. Bind Therapeutics Product
Table 75. Bind Therapeutics Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 76. Bind Therapeutics Recent Development
Table 77. Boston Scientific Corporation Company Details
Table 78. Boston Scientific Corporation Business Overview
Table 79. Boston Scientific Corporation Product
Table 80. Boston Scientific Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 81. Boston Scientific Corporation Recent Development
Table 82. BTG plc Company Details
Table 83. BTG plc Business Overview
Table 84. BTG plc Product
Table 85. BTG plc Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 86. BTG plc Recent Development
Table 87. CeloNova BioSciences, Inc. Company Details
Table 88. CeloNova BioSciences, Inc. Business Overview
Table 89. CeloNova BioSciences, Inc. Product
Table 90. CeloNova BioSciences, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 91. CeloNova BioSciences, Inc. Recent Development
Table 92. Cook Medical, Inc. Company Details
Table 93. Cook Medical, Inc. Business Overview
Table 94. Cook Medical, Inc. Product
Table 95. Cook Medical, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 96. Cook Medical, Inc. Recent Development
Table 97. Cospheric LLC Company Details
Table 98. Cospheric LLC Business Overview
Table 99. Cospheric LLC Product
Table 100. Cospheric LLC Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 101. Cospheric LLC Recent Development
Table 102. Covidien, plc Business Overview
Table 103. Covidien, plc Product
Table 104. Covidien, plc Company Details
Table 105. Covidien, plc Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 106. Covidien, plc Recent Development
Table 107. Eckert & Ziegler BEBIG Company Details
Table 108. Eckert & Ziegler BEBIG Business Overview
Table 109. Eckert & Ziegler BEBIG Product
Table 110. Eckert & Ziegler BEBIG Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 111. Eckert & Ziegler BEBIG Recent Development
Table 112. EmboMedics, Inc. Company Details
Table 113. EmboMedics, Inc. Business Overview
Table 114. EmboMedics, Inc. Product
Table 115. EmboMedics, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 116. EmboMedics, Inc. Recent Development
Table 117. Kobo Products, Inc. Company Details
Table 118. Kobo Products, Inc. Business Overview
Table 119. Kobo Products, Inc. Product
Table 120. Kobo Products, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 121. Kobo Products, Inc. Recent Development
Table 122. Merit Medical Systems, Inc. Company Details
Table 123. Merit Medical Systems, Inc. Business Overview
Table 124. Merit Medical Systems, Inc. Product
Table 125. Merit Medical Systems, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 126. Merit Medical Systems, Inc. Recent Development
Table 127. Mo-Sci Corporation Company Details
Table 128. Mo-Sci Corporation Business Overview
Table 129. Mo-Sci Corporation Product
Table 130. Mo-Sci Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 131. Mo-Sci Corporation Recent Development
Table 132. Nanobiotix Company Details
Table 133. Nanobiotix Business Overview
Table 134. Nanobiotix Product
Table 135. Nanobiotix Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 136. Nanobiotix Recent Development
Table 137. Polysciences, Inc. Company Details
Table 138. Polysciences, Inc. Business Overview
Table 139. Polysciences, Inc. Product
Table 140. Polysciences, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 141. Polysciences, Inc. Recent Development
Table 142. Sirtex Medical, Inc. Company Details
Table 143. Sirtex Medical, Inc. Business Overview
Table 144. Sirtex Medical, Inc. Product
Table 145. Sirtex Medical, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 146. Sirtex Medical, Inc. Recent Development
Table 147. Terumo Corporation Company Details
Table 148. Terumo Corporation Business Overview
Table 149. Terumo Corporation Product
Table 150. Terumo Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020) (Million US$)
Table 151. Terumo Corporation Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Type: 2020 VS 2026
Figure 2. Embolization Particles - Drug Eluting Beads Features
Figure 3. Polyvinyl Alcohol Particles Features
Figure 4. Microspheres Features
Figure 5. Gelatin-Based Embolization Devices Features
Figure 6. Selective Internal Radiation Therapy Features
Figure 7. Holmium-Based Microspheres Features
Figure 8. Liquid Embolics - Onyx Features
Figure 9. Other Features
Figure 10. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Application: 2020 VS 2026
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. Novel Drug Delivery Systems for Cancer Therapy Report Years Considered
Figure 15. Global Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Regions: 2020 VS 2026
Figure 17. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Players in 2019
Figure 20. Global Top Novel Drug Delivery Systems for Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Novel Drug Delivery Systems for Cancer Therapy as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Novel Drug Delivery Systems for Cancer Therapy Revenue in 2019
Figure 22. North America Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Advanced Medical Isotope Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Advanced Medical Isotope Corporation Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 28. Bind Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Bind Therapeutics Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 30. Boston Scientific Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Boston Scientific Corporation Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 32. BTG plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. BTG plc Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 34. CeloNova BioSciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. CeloNova BioSciences, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 36. Cook Medical, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Cook Medical, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 38. Cospheric LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Cospheric LLC Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 40. Covidien, plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Covidien, plc Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 42. Eckert & Ziegler BEBIG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Eckert & Ziegler BEBIG Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 44. EmboMedics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. EmboMedics, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 46. Kobo Products, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Kobo Products, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 48. Merit Medical Systems, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Merit Medical Systems, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 50. Mo-Sci Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Mo-Sci Corporation Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 52. Nanobiotix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Nanobiotix Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 54. Polysciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Polysciences, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 56. Sirtex Medical, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Sirtex Medical, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 58. Terumo Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Terumo Corporation Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2015-2020)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
  • Global Lumbar Artificial Disc Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 118
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Metal - Biopolymer Segment by Application - Hospitals - Ambulatory Surgical Centers......
  • Global Artificial Discs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 115
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Cervical Artificial Disc - Lumbar Artificial Disc Segment by Application - Hospitals ......
  • Global Choroidal Neovascularization Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 91
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Intravenous - Intravitreal Segment by Application - Extreme Myopia - Malignant Myopic......
  • Global Cerebrospinal Fluid (CSF) Management Devices Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 97
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - CSF Shunts - CSF Drainage Systems Segment by Application - Hospitals - Ambulatory Sur......
  • Global Cerebral and Tissue Oximetry Devices Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 122
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Portable - Desktop Segment by Application - Clinical - Hospitals - Others......
  • Global Axial Bone Densitometer Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - DEXA Axial Bone Densitometer - QCT Axial Bone Densitometer Segment by Application - Hospital......
  • Global CPAP Humidifier Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 115
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tem-Control - Others Segment by Application - Hospital - Residential - Others......
  • Global Transfer Bench Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 95
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Retractable - Ordinary Segment by Application - Residential - Commercial - Oth......
  • Global CPAP Humidifiers Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 119
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tem-Control - Others Segment by Application - Hospital - Residential - Others......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs